LISTEN UP, PRIVATE! There's a NEW diet in town and it's not taking any GUFF from you or anybody else! That's because it's set up like a BOOTCAMP, you see. It's going to be TOUGH! It's going to be ...

Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis (MG) and initial results from Period 1 of a mid-stage study of ...

Elon Musk's Grok AI model has come under the IT ministry’s radar for generating inflammatory content on social media platform X. “The government has taken note of this, and we are deeply engaged with ...

Women with the highest Empirical Dietary Inflammatory Pattern scores faced a more than 2-fold increased risk of developing gout. Women who follow a pro-inflammatory diet are more than twice as ...

“We are excited to share positive results from our MG and CIDP studies. While neurologists and patients are very enthusiastic about currently approved FcRn inhibitors, they tell us that they ...

Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the higher dose arm (with 74% mean IgG reduction) and a ...

Food scientists have reclassified dietary fibers -- beyond just soluble and insoluble -- to better guide nutritional decisions and drive targeted health food products. Australian food scientists ...

The pivotal Phase III study in myasthenia gravis met its primary endpoint with meaningful improvements in MG-ADL across both higher and lower dose arms. Immunovant has shared positive results of its ...

Pivotal study in MG met primary endpoint of change from baseline in MG-ADL in AChR+ population at 12 weeks, with a 5.6 point improvement in the higher dose arm (with 74% mean IgG reduction) and a 4.7 ...